Skip to main content
logo
Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS · Delayed Price · Currency is USD
0.7690
+0.3250 (73.20%)
At close: Jun 30, 2026

Nika Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0000.0200
Cash & Short-Term Investments
0000.0200
Cash Growth
-92.01%-9.31%-89.37%2168.06%116.54%-75.23%
Prepaid Expenses
0.020.020.02---
Total Current Assets
0.020.020.020.0200
Total Assets
0.020.020.020.0200

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt
0.330.320.240.10.02-
Other Current Liabilities
-----0.01
Total Current Liabilities
0.330.320.240.10.020.01
Other Long-Term Liabilities
-----0.01
Total Liabilities
0.330.320.240.10.020.02

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.090.090.04
Additional Paid-In Capital
8.68.68.63.233.230.09
Retained Earnings
-9.02-9-8.93-3.4-3.34-0.15
Total Common Equity
-0.31-0.3-0.22-0.08-0.02-0.02
Shareholders' Equity
-0.31-0.3-0.22-0.08-0.02-0.02
Total Liabilities & Equity
0.020.020.020.0200

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.330.320.240.10.02-
Net Cash (Debt)
-0.33-0.32-0.24-0.08-0.020
Net Cash Growth
------75.23%
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.00-
Filing Date Shares Outstanding
1,0491,0481,026876.09876.09396.09
Total Common Shares Outstanding
1,0491,0481,019876.09876.09396.09
Working Capital
-0.31-0.3-0.22-0.08-0.02-0.01
Book Value Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
Tangible Book Value
-0.31-0.3-0.22-0.08-0.02-0.02
Tangible Book Value Per Share
-0.00-0.00-0.00-0.00-0.00-0.00